Join today and have your say! It’s FREE!
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H


Primary Symbol: CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Post by HighSkies2019on Nov 24, 2020 10:08am
855 Views
Post# 31959971

Contact Sec Direct !!!

Contact Sec Direct !!!Maybe we all need to start contacting the securities directly inquiring about the halt .... I am not here to knock anyone if they are pro or No Kly or the honesty of anyone's imput.....for me until I see something in a NR from Kly do I consider of true value on moving forward .... Rob indicated that Sec allowed him to give an early NR on Nov 10 .... Nov 4th is when they applied to be reinstated .... this is a long weekend for the U.S Thanks Giving .... so unless we get something by tomorrow I cant see anything till after the holiday .... Q3 I guess was indicated at the end of this week .....and there have been different responses apparently from Rob to a couple different investors .... one indicated the hold up.at sec end ...another indicates Kly owing money ....well the Sec did clear of under the CTO on sedar that payment was made...that was the num 3 that was listed against them...and that is when Rob put out his last NR .... patients is running thin with everyone ...glta
<< Previous
Bullboard Posts
Next >>